INBX

Inhibrx Biosciences, Inc. SEC filings

Every EDGAR filing for Inhibrx Biosciences, Inc. (INBX), newest first, with AI summaries and stories.

Ticker
INBX
CIK
2007919
Sector
Biotech and pharma
Latest filing
4d

Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Get an email when Inhibrx Biosciences, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Insider activity

Notable buy: CEO bought $208K

  • CEO bought $208K
  • CEO bought $210K
  • CEO bought $9K

All INBX insider trades

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  1. ROUTINE4/AInhibrx Biosciences, Inc.INBX

    4 insider filings

    Douglas Forsyth, insider filing for INBX (amended)

    Show all 4
    • 4/AInsider filing for INBX (amended)
    • 4/AInsider filing for INBX (amended)
    • 4/AInsider filing for INBX (amended)
    • 4/AInsider filing for INBX (amended)

    Douglas Forsyth, reporting

  2. ROUTINE4Inhibrx Biosciences, Inc.INBX

    3 insider filings

    Jon Faiz Kayyem, insider filing for INBX

    Show all 3
    • 4Insider filing for INBX
    • 4Insider filing for INBX
    • 4Insider filing for INBX

    Jon Faiz Kayyem, reporting

  3. ROUTINESCHEDULE 13G/AInhibrx Biosciences, Inc.INBX

    3 13G filings

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

    Show all 3
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13GOwnership stake disclosure
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    PERCEPTIVE ADVISORS LLC, filed by

  4. ROUTINE4Inhibrx Biosciences, Inc.INBX

    4 insider filings

    Kristiina MD Vuori, insider filing for INBX

    Show all 4
    • 4Insider filing for INBX
    • 4Insider filing for INBX
    • 4Insider filing for INBX
    • 4Insider filing for INBX

    Kristiina Vuori Md, reporting

Older filings on EDGAR